The concomitant use of VYVANSE and CYP2D6 inhibitors may increase the exposure of dextroamphetamine, the active metabolite of VYVANSE compared to the use of the drug alone and increase the risk of serotonin syndrome. Slowing of growth (height and weight) rein children. Children should have their height and weight checked https://torreyb013atx6.fare-blog.com/profile